UCSC Chemical Screening Center symposium features drug discovery talks
The center will hold a Grand Reopening Celebration and Research Symposium on Friday, May 5, marking a major upgrade with new state-of-the-art equipment
The center will hold a Grand Reopening Celebration and Research Symposium on Friday, May 5, marking a major upgrade with new state-of-the-art equipment
Researchers at UC Santa Cruz have developed a new puzzle challenge for the online game Eterna, enlisting players to help design a novel RNA drug to treat hemophilia A.
NIH MIRA grant funds biochemist Scott Lokey’s efforts to develop complex, membrane-permeable molecules as next-generation therapeutic agents
The new system can increase reproducibility in cerebral organoid research and shows promise for lowering levels of cellular stress
Sponsored by UCSC’s Global and Community Health Program, Garrett’s talk highlighted the urgent need to strengthen public health infrastructure
A new study by researchers at UC Santa Cruz shows how a common type of epigenetic modification can be transmitted via sperm not only from parents to offspring, but to the next generation (“grandoffspring”) as well. This is called “transgenerational epigenetic inheritance,” and it may explain how a person’s health and development could be influenced by the experiences of his or her parents and grandparents.
New understanding of how the transporter protein cystinosin functions may lead to better treatments for a devastating genetic disease.
UCSC scientists reported three crystal structures of periodic rippled beta sheets, a novel protein structure with potential applications in biomedicine and materials science.
Laura Sanchez, associate professor of chemistry and biochemistry at UCSC, has been chosen to receive the 2022 ACS Infectious Diseases Young Investigator Award.
Kimmey’s lab is investigating how susceptibility to infections is influenced by the daily biological cycles known as circadian rhythms.
With the new award, IBSC directors have now brought in nearly $12 million to fund the future of bimolecular research at UCSC.
UC Santa Cruz has joined the University of California Drug Discovery Consortium (UC DDC), a cross-campus initiative aimed at building a drug discovery community that actively promotes research translation through industry partnerships.